Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by de Seze, J.
Right arrow Articles by Vermersch, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Seze, J.
Right arrow Articles by Vermersch, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 124, No. 8, 1509-1521, August 2001
© 2001 Oxford University Press

Acute myelopathies

Clinical, laboratory and outcome profiles in 79 cases

Jérôme de Seze1, Tanya Stojkovic1, Guillaume Breteau1, Christian Lucas1, Ulrich Michon-Pasturel2, Jean-Yves Gauvrit3, Eric Hachulla2, François Mounier-Vehier4, Jean-Pierre Pruvo3, Didier Leys1, Alain Destée1, Pierre-Yves Hatron2 and Patrick Vermersch1

1 Department of Neurology, 2 Department of Neuroradiology and 3 Department of Internal Medicine, CHU de Lille, 4 Department of Neurology, CH de Lens, France

Correspondence to: Dr J. de Seze, Department of Neurology, Hôpital Roger Salengro, CHU de Lille, 59037 Lille Cedex, France E-mail: j-deseze{at}chru-lille.fr

The main aetiologies of acute myelopathy (AM) are: multiple sclerosis, systemic disease (SD), spinal cord infarct (SCI), parainfectious myelopathy (PIM) and delayed radiation myelopathy (DRM). Although a large amount of data have been published for each individual aetiology, comparison studies are scarce. The aim of this study was to assess the various aetiological and outcome profiles of AM. We studied 79 cases: 34 (43%) in multiple sclerosis; 13 (16.5%) in SD; 11 (14%) in SCI; five (6%) in PIM; and three (4%) in DRM. Myelopathies were of unknown origin in 13 (16.5%) patients. We evaluated clinical, spinal cord and brain MRI, CSF and evoked potentials data at admission, MRI outcome at 6 months and clinical outcome at 12 months. A statistical comparison of clinical, laboratory and outcome data was only performed between multiple sclerosis, SD and SCI patients due to the small number of cases in the other groups. A motor deficit was more frequent in SD and SCI than in multiple sclerosis where initial symptoms were predominantly sensory (P < 0.001). Spinal cord MRI showed lateral or posterior lesions of less than two vertebral levels in multiple sclerosis, in contrast to SD and SCI, where lesions involved more vertebral levels and were centromedullar (P < 0.001). Brain MRI was most frequently abnormal in multiple sclerosis (68%), but was also abnormal in 31% of SD patients (P < 0.05). Oligoclonal bands in CSF were more frequent in multiple sclerosis than in SD (P < 0.001) and were never found in SCI. Clinical outcome at 12 months was good in 88% of multiple sclerosis cases, and poor or fair in 91% of SCI and 77% of SD. Aetiologies of AM may be differentiated on the basis of clinical, spinal cord and brain MRI, CSF and outcome data, and allow a probable diagnosis to be made in previously undetermined cases. These findings may have therapeutic implications for cases with a questionable diagnosis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
LupusHome page
N. Agmon-Levin, S. Kivity, M. Szyper-Kravitz, and Y. Shoenfeld
Transverse myelitis and vaccines: a multi-analysis
Lupus, November 1, 2009; 18(13): 1198 - 1204.
[Abstract] [PDF]


Home page
Mult SclerHome page
J. Young, S. Quinn, M. Hurrell, and B. Taylor
Clinically isolated acute transverse myelitis: prognostic features and incidence
Multiple Sclerosis, November 1, 2009; 15(11): 1295 - 1302.
[Abstract] [PDF]


Home page
NeurologyHome page
C. Salvarani, R. D. Brown Jr, K. T. Calamia, T.J.H. Christianson, J. Huston III, J. F. Meschia, C. Giannini, D. V. Miller, and G. G. Hunder
Primary CNS vasculitis with spinal cord involvement
Neurology, June 10, 2008; 70(24_Part_2): 2394 - 2400.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. de Seze
Monophasic Acute, Recurrent, and Multiphasic Disseminated Encephalomyelitis and Multiple Sclerosis--Reply
Arch Neurol, May 1, 2008; 65(5): 676 - 676.
[Full Text] [PDF]


Home page
Arch NeurolHome page
J. de Seze
Multiple Sclerosis and Recurrent Disseminated Encephalomyelitis Are Different Diseases--Reply
Arch Neurol, May 1, 2008; 65(5): 674 - 675.
[Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
J.S. Ross
ATM--OMG!
AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 618 - 618.
[Full Text] [PDF]


Home page
NeurologyHome page
F. S. Pidcock, C. Krishnan, T. O. Crawford, C. F. Salorio, M. Trovato, and D. A. Kerr
Acute transverse myelitis in childhood: Center-based analysis of 47 cases
Neurology, May 1, 2007; 68(18): 1474 - 1480.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. Novy, A. Carruzzo, P. Maeder, and J. Bogousslavsky
Spinal Cord Ischemia: Clinical and Imaging Patterns, Pathogenesis, and Outcomes in 27 Patients.
Arch Neurol, August 1, 2006; 63(8): 1113 - 1120.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J Bruna, S Martinez-Yelamos, A Martinez-Yelamos, F Rubio, and T Arbizu
Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases
Multiple Sclerosis, April 1, 2006; 12(2): 169 - 173.
[Abstract] [PDF]


Home page
NeurologyHome page
B. A.C. Cree and D. M. Wingerchuk
Acute transverse myelitis: Is the "idiopathic" form vanishing?
Neurology, December 27, 2005; 65(12): 1857 - 1858.
[Full Text] [PDF]


Home page
NeurologyHome page
J. de Seze, C. Lanctin, C. Lebrun, I. Malikova, C. Papeix, S. Wiertlewski, J. Pelletier, O. Gout, C. Clerc, C. Moreau, et al.
Idiopathic acute transverse myelitis: Application of the recent diagnostic criteria
Neurology, December 27, 2005; 65(12): 1950 - 1953.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
C. Krishnan and D. A. Kerr
Idiopathic Transverse Myelitis
Arch Neurol, June 1, 2005; 62(6): 1011 - 1013.
[Full Text] [PDF]


Home page
NeurologyHome page
A. V. Krishnan and G. M. Halmagyi
Acute transverse myelitis in SLE
Neurology, June 8, 2004; 62(11): 2087 - 2087.
[Full Text] [PDF]


Home page
StrokeHome page
K. Nedeltchev, T. J. Loher, F. Stepper, M. Arnold, G. Schroth, H. P. Mattle, and M. Sturzenegger
Long-Term Outcome of Acute Spinal Cord Ischemia Syndrome
Stroke, February 1, 2004; 35(2): 560 - 565.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J de Seze, C Lebrun, T Stojkovic, D Ferriby, M Chatel, and P Vermersch
Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis
Multiple Sclerosis, October 1, 2003; 9(5): 521 - 525.
[Abstract] [PDF]


Home page
NeurologyHome page
Transverse Myelitis Consortium Working Group*
Proposed diagnostic criteria and nosology of acute transverse myelitis
Neurology, August 27, 2002; 59(4): 499 - 505.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.